77 related articles for article (PubMed ID: 15523412)
1. Re: "The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators".
Sasada T; Takabayashi A
Surgery; 2004 Nov; 136(5):1101. PubMed ID: 15523412
[No Abstract] [Full Text] [Related]
2. Re: "Thorough intraoperative analysis of breast sentinel lymph node biopsies: Histologic and immunohistochemical findings".
Griswold RD
Surgery; 2004 Nov; 136(5):1101-2. PubMed ID: 15523411
[No Abstract] [Full Text] [Related]
3. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
Georgiannos SN; Renaut A; Goode AW; Sheaff M
Surgery; 2003 Nov; 134(5):827-34. PubMed ID: 14639362
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tumour infiltrating lymphocytes in human breast cancer.
Chin Y; Janssens J; Bleus J; Vandepitte J; Vandenbrande J; Raus J
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():27-31. PubMed ID: 8298448
[No Abstract] [Full Text] [Related]
5. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.
Xu ZL; Zhu XQ; Lu P; Zhou Q; Zhang J; Wu F
Ultrasound Med Biol; 2009 Jan; 35(1):50-7. PubMed ID: 18950932
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.
Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN
Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
8. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.
Matkowski R; Gisterek I; Halon A; Lacko A; Szewczyk K; Staszek U; Pudelko M; Szynglarewicz B; Szelachowska J; Zolnierek A; Kornafel J
Anticancer Res; 2009 Jul; 29(7):2445-51. PubMed ID: 19596912
[TBL] [Abstract][Full Text] [Related]
10. Interactions between the immune system and breast cancer.
Ogmundsdóttir HM; Pétursdóttir I; Gudmundsdóttir I
Acta Oncol; 1995; 34(5):647-50. PubMed ID: 7546833
[TBL] [Abstract][Full Text] [Related]
11. Analysis of T-helper type 1 and 2 cells and T-cytotoxic type 1 and 2 cells of sentinel lymph nodes in breast cancer.
Ehi K; Ishigami S; Masamoto I; Uenosono Y; Natsugoe S; Arigami T; Arima H; Kijima Y; Yoshinaka H; Yanagita S; Kozono T; Funasako Y; Maruyama I; Aikou T
Oncol Rep; 2008 Mar; 19(3):601-7. PubMed ID: 18288390
[TBL] [Abstract][Full Text] [Related]
12. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
[TBL] [Abstract][Full Text] [Related]
13. Biopsy variability of lymphocytic infiltration in breast cancer subtypes and the ImmunoSkew score.
Khan AM; Yuan Y
Sci Rep; 2016 Nov; 6():36231. PubMed ID: 27812028
[TBL] [Abstract][Full Text] [Related]
14. [Sentinel nodes identification efficacy prognostic criteria in breast cancer].
Kokhreidze ID; Nemsadze GG; Gersamiia GK; Dzagnidze GB; Dzhandzhaliia MT
Georgian Med News; 2005 Feb; (119):31-4. PubMed ID: 15834176
[TBL] [Abstract][Full Text] [Related]
15. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
16. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
Ryschich E; Nötzel T; Hinz U; Autschbach F; Ferguson J; Simon I; Weitz J; Fröhlich B; Klar E; Büchler MW; Schmidt J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):498-504. PubMed ID: 15701833
[TBL] [Abstract][Full Text] [Related]
17. [The role of sentinel node biopsy in breast cancer surgery].
Stańczyk M; Dziekiewicz M; Maruszyński M; Olszewski WL
Pol Merkur Lekarski; 2005 Aug; 19(110):245-8. PubMed ID: 16245445
[TBL] [Abstract][Full Text] [Related]
18. The role of sentinel lymph-node biopsy (SLNB) in the treatment of breast cancer.
Marrazzo A; Taormina P; David M; Casà L; Lo Gerfo D; Noto A; Riili I; Ficola U; Russo L
Chir Ital; 2006; 58(3):299-304. PubMed ID: 16845865
[TBL] [Abstract][Full Text] [Related]
19. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in breast cancer.
Fortunato L; Mascaro A; Amini M; Farina M; Vitelli CE
Surg Oncol Clin N Am; 2008 Jul; 17(3):673-99, x. PubMed ID: 18486889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
